The main purpose of this legislation is to create an interagency task force that will enhance collaboration between the United States Patent and Trademark Office (USPTO) and the Food and Drug Administration (FDA). The goal is to improve the sharing of information and provide technical assistance regarding patents, particularly those related to human drugs and biological products. This initiative aims to ensure that patent examiners have access to relevant information that can help them make informed decisions during the patent examination process.